Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000204067 | SCV000261622 | benign | Hypertrophic cardiomyopathy 14 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000482862 | SCV000565703 | benign | not specified | 2017-11-07 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
CHEO Genetics Diagnostic Laboratory, |
RCV001171185 | SCV001333877 | benign | Cardiomyopathy | 2018-03-08 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000482862 | SCV001360442 | benign | not specified | 2019-08-16 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000482862 | SCV001743744 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000482862 | SCV001951763 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000482862 | SCV001966720 | benign | not specified | no assertion criteria provided | clinical testing |